GE Healthcare announced this week that it is partnering with several companies to develop a line of PET tracers in the hopes of better predicting patients’ responses to immunotherapies.

General surgery in robotics is taking off, and its advantages are helping doctors perform more procedures and reduce risks, according to a profile in The New Yorker.

Five-year results of the ABSORB III trial suggest that, while target lesion failure and scaffold thrombosis have remained apparent in patients implanted with bioresorbable vascular scaffolds, the poor outcomes associated with BVS seemed to subside after three years, when the stents had completely dissolved.

Brain scans contain vast amounts of patient data, some as valuable as that within your DNA. In a recent opinion piece published in Wired, professor of radiology and biomedical imaging at Yale, Evan D. Morris, PhD, argued that we need to do more to protect these valuable images.

CMS has finalized a proposed rule to the Medicaid Disproportionate Share Hospital (DSH) program that will result in $4 billion in payment cuts in 2020.

Siemens Healthineers announced Thursday, Sept. 26, that it has received FDA clearance for three modules of the company’s AI-Rad Companion Chest CT software.

Twenty-six percent of heart attack survivors are confused about the role aspirin plays in secondary MI prevention, according to a recent survey from Bayer—a phenomenon that can be attributed in large part to an onslaught of conflicting headlines in the news this summer.

Screening ultrasound (US) examinations after digital breast tomosynthesis (DBT) and after digital mammography (DM) result in comparable cancer detection rates, according to a new study published in the American Journal of Roentgenology.

Authors of a new study published Sept. 20 in the Journal of Nuclear Medicine argue that gallium-68 (68Ga) prostate-specific membrane antigen (PSMA)-11 PET/CT imaging can offer additional insight into bone metastases in prostate cancer patients and should be more widely used.

Several major charitable organizations are banding together to prevent 6 million deaths in 10 countries by 2030 using Big Data to provide precision medicine.